Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism-Reference-Cited by-同舟云学术

Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism

Published:2006-06 Issue:3 Volume:16 Page:317-322
ISSN:0959-437X
Container-title:Current Opinion in Genetics & Development
language:en
Short-container-title:Current Opinion in Genetics & Development

Author:

Luzzatto Lucio

Publisher

Elsevier BV

Subject

Developmental Biology,Genetics

Reference42 articles.

1. Paroxysmal nocturnal hemoglobinuria;Luzzatto,2006

2. Diagnosis and management of paroxysmal nocturnal hemoglobinuria;Parker;Blood,2005

3. Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion into lipid bilayers;Meri;Immunology,1990

4. Paroxysmal nocturnal haemoglobinuria;Dacie,1999

5. Murine embryonic stem cells without PIG-A gene activity are competent for PNH-like hematopoiesis but not for clonal expansion;Rosti;J Clin Invest,1997

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA;Journal of Comparative Effectiveness Research;2023-10

2. Pathological Background and Clinical Procedures in Oral Surgery Haemostasis Disorders: A Narrative Review;Applied Sciences;2023-02-05

3. Attack of the Clones: A Patient With Untreated Aplastic Anemia Presenting With Classical Paroxysmal Nocturnal Hemoglobinuria;Cureus;2023-01-23

4. Somatic Mutations in “Benign” Disease;New England Journal of Medicine;2021-05-27

5. Komplementinhibitoren: neue Therapeutika – neue Indikationen;Transfusionsmedizin;2021-05